Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B A Zonnenberg

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1996
Phase 1 study of rhenium-186-HEDP in patients with bone metastases originating from breast cancerJ M de Klerk, A D van het Schip, B A Zonnenberg, et al.
European Journal of Nuclear Medicine|July 10, 1999
Holmium-166 poly lactic acid microspheres applicable for intra-arterial radionuclide therapy of hepatic malignancies: effects of preparation and neutron activation techniquesJ F Nijsen, B A Zonnenberg, J R Woittiez, et al.
Journal of Biomedical Materials Research. Part A|March 6, 2007
Characterization of holmium loaded alginate microspheres for multimodality imaging and therapeutic applicationsS W Zielhuis, J H Seppenwoolde, C J G Bakker, et al.
The Journal of Clinical Endocrinology and Metabolism|June 21, 2007
A phase II trial of imatinib therapy for metastatic medullary thyroid carcinomaJ W B de Groot, B A Zonnenberg, P Quarles van Ufford-Mannesse, et al.
European Journal of Nuclear Medicine|October 1, 1994
Dose escalation study of rhenium-186 hydroxyethylidene diphosphonate in patients with metastatic prostate cancerJ M de Klerk, B A Zonnenberg, A D van het Schip, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 1996
Transient cranial neuropathy in prostatic cancer with bone metastases after rhenium-186-HEDP treatmentJ M de Klerk, B A Zonnenberg, H G Krouwer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1994
Evaluation of thrombocytopenia in patients treated with rhenium-186-HEDP: guidelines for individual dosage recommendationsJ M de Klerk, A D van het Schip, B A Zonnenberg, et al.
Current Medicinal Chemistry. Anti-Cancer Agents|July 5, 2005
Lanthanide bearing microparticulate systems for multi-modality imaging and targeted therapy of cancerS W Zielhuis, J F W Nijsen, J H Seppenwoolde, et al.
Neurology|January 10, 2001
PCV chemotherapy for recurrent glioblastoma multiformeA C Kappelle, T J Postma, M J Taphoorn, et al.
Anticancer Research|May 1, 1997
Treatment of metastatic bone pain using the bone seeking radiopharmaceutical Re-186-HEDPJ M De Klerk, B A Zonnenberg, G H Blijham, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1996
Phase 1 study of rhenium-186-HEDP in patients with bone metastases originating from breast cancerJ M de Klerk, A D van het Schip, B A Zonnenberg, et al.
European Journal of Nuclear Medicine|July 10, 1999
Holmium-166 poly lactic acid microspheres applicable for intra-arterial radionuclide therapy of hepatic malignancies: effects of preparation and neutron activation techniquesJ F Nijsen, B A Zonnenberg, J R Woittiez, et al.
Journal of Biomedical Materials Research. Part A|March 6, 2007
Characterization of holmium loaded alginate microspheres for multimodality imaging and therapeutic applicationsS W Zielhuis, J H Seppenwoolde, C J G Bakker, et al.
The Journal of Clinical Endocrinology and Metabolism|June 21, 2007
A phase II trial of imatinib therapy for metastatic medullary thyroid carcinomaJ W B de Groot, B A Zonnenberg, P Quarles van Ufford-Mannesse, et al.
European Journal of Nuclear Medicine|October 1, 1994
Dose escalation study of rhenium-186 hydroxyethylidene diphosphonate in patients with metastatic prostate cancerJ M de Klerk, B A Zonnenberg, A D van het Schip, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 1996
Transient cranial neuropathy in prostatic cancer with bone metastases after rhenium-186-HEDP treatmentJ M de Klerk, B A Zonnenberg, H G Krouwer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1994
Evaluation of thrombocytopenia in patients treated with rhenium-186-HEDP: guidelines for individual dosage recommendationsJ M de Klerk, A D van het Schip, B A Zonnenberg, et al.
Current Medicinal Chemistry. Anti-Cancer Agents|July 5, 2005
Lanthanide bearing microparticulate systems for multi-modality imaging and targeted therapy of cancerS W Zielhuis, J F W Nijsen, J H Seppenwoolde, et al.
Neurology|January 10, 2001
PCV chemotherapy for recurrent glioblastoma multiformeA C Kappelle, T J Postma, M J Taphoorn, et al.
Anticancer Research|May 1, 1997
Treatment of metastatic bone pain using the bone seeking radiopharmaceutical Re-186-HEDPJ M De Klerk, B A Zonnenberg, G H Blijham, et al.
Pageof 5